MannKind shares pop 26% after $5M milestone, drop after Q1 earnings miss
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Bank of the Sierra announces Q1 earnings
Sierra Bancorp, the parent company of Bank of the Sierra, announced its results for the first quarter of 2026 on April 28, noting that consolidated net income was $12.5 million for the quarter, up from $9.3 million in the same quarter a year ago. Bank of the Sierra is headquartered in Porterville but has 10 Read More →
Amgen invests $300M into U.S. manufacturing capabilites
Thousand Oaks-based Amgen continues to invest in its onshore capabilities, after the biotech giant announced plans to invest an additional $300 million in its U.S. manufacturing network to further expand U.S.-based production capacity. Announced May 4, Amegn plans to expand its biologics manufacturing facility in Puerto Rico, which will strengthen existing advanced manufacturing roles, support Read More →
Amgen’s Q1 total revenues up 6% to $8.6 billion
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
AppFolio shares pop 11% after strong Q1 earnings
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen executive VP/chief tech officer retiring after 21 years
Biotech giant Amgen on April 22 announced the retirement of David Reese, executive vice president and chief technology officer, who has been with the Thousand Oaks-based company for 21 years. Reese, an M.D., joined the global life sciences powerhouse in 2005 as a clinical development leader in oncology and later served as executive vice president of research and development Read More →
